Anagliptin Decreases Serum Lathosterol Level in Patients With Type 2 Diabetes: A Pilot Study

Expert Opinion on Pharmacotherapy - United Kingdom
doi 10.1517/14656566.2015.1057120
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

A Prospective Study of Serum Testosterone Level in Type 2 Diabetes Mellitus Patients

Journal of Medical Science And clinical Research
2018English

Effect of Anagliptin on Glycemic and Lipid Profile in Patients With Type 2 Diabetes Mellitus

Journal of Clinical Medicine Research
2018English

Luseogliflozin Reduces Epicardial Fat Accumulation in Patients With Type 2 Diabetes: A Pilot Study

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2017English

Serum Osteocalcin Level and Its Association With Carotid Atherosclerosis in Patients With Type 2 Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2013English

Serum Leptin Concentration in Patients With Type 2 Diabetes

Current Issues in Pharmacy and Medical Sciences
2015English

Metabolic Syndrome and Serum Liver Enzymes Level at Patients With Type 2 Diabetes Mellitus

Medicinski Arhiv
Medicine
2015English

Study of Risk Factors for Erectile Dysfunction in Patients With Type 2 Diabetes Mellitus: Correlation to Serum Testosterone Level

Alexandria Journal of Medicine
2018English

Correlation of Serum Triglyceride Level With Carotid Intima Media Thickness in Type-2 Diabetes Mellitus Patients

Scholars Journal of Applied Medical Sciences
2020English

Study of Serum Zinc Status Among Type 2 Diabetes Mellitus Patients

International Journal of Advances in Medicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy